Last 12,750 KRW
Change Today +200.00 / 1.59%
Volume 52.9K
092730 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:15 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

neopharm co ltd (092730) Snapshot

Open
12,700
Previous Close
12,550
Day High
12,750
Day Low
12,350
52 Week High
08/20/14 - 12,950
52 Week Low
02/4/14 - 4,355
Market Cap
95.1B
Average Volume 10 Days
129.9K
EPS TTM
258.00
Shares Outstanding
7.5M
EX-Date
12/27/13
P/E TM
49.4x
Dividend
100.00
Dividend Yield
0.78%
Current Stock Chart for NEOPHARM CO LTD (092730)

Related News

No related news articles were found.

neopharm co ltd (092730) Related Businessweek News

No Related Businessweek News Found

neopharm co ltd (092730) Details

NeoPharm Co., Ltd. manufactures and sells skin care products in South Korea and internationally. The company offers skin care products for atopic, dry, and sensitive skin under ATOPALM brand name; and soothing cream and lotion, and foaming cleanser products under the ZEROID brand name. It also provides anti-aging cosmeceutical products, including foam and oil cleanser, toner, emulsion, cream, facial and neck mask, multi-functional BB cream, sun protector, white watering and firming serum, eye cream, and after shave essence skin and lotion under the Dr. MLE brand name. The company was founded in 2000 and is headquartered in Daejeon, South Korea.

Founded in 2000

neopharm co ltd (092730) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

neopharm co ltd (092730) Key Developments

Neopharm Co Ltd, Annual General Meeting, Mar 22, 2013

Neopharm Co Ltd, Annual General Meeting, Mar 22, 2013., at 09:00 Korea Standard Time. Location: 928 bungee NEO Farm NEO headquarters conference room. Agenda: To consider and approve article 13 financial statement and appropriation of retained earnings statement (draft); to consider some changes incorporation; to consider appointment of inside directors; to approve directors' remuneration limit; and to approve the audit fees limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
092730:KS 12,750.00 KRW +200.00

092730 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 092730.
View Industry Companies
 

Industry Analysis

092730

Industry Average

Valuation 092730 Industry Range
Price/Earnings 42.4x
Price/Sales 4.5x
Price/Book 3.1x
Price/Cash Flow 37.0x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOPHARM CO LTD, please visit www.neopharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.